797 related articles for article (PubMed ID: 14599847)
1. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
Mukherjee R; Chaturvedi P; Qin HY; Singh B
J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
[TBL] [Abstract][Full Text] [Related]
2. Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+regulatory T cells.
Kohm AP; Miller SD
J Autoimmun; 2003 Nov; 21(3):261-71. PubMed ID: 14599851
[TBL] [Abstract][Full Text] [Related]
3. Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.
Liu E; Moriyama H; Paronen J; Abiru N; Miao D; Yu L; Taylor RM; Eisenbarth GS
J Autoimmun; 2003 Nov; 21(3):213-9. PubMed ID: 14599846
[TBL] [Abstract][Full Text] [Related]
4. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
6. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
7. Induction of autoantigen-specific Th2 and Tr1 regulatory T cells and modulation of autoimmune diabetes.
Chen C; Lee WH; Yun P; Snow P; Liu CP
J Immunol; 2003 Jul; 171(2):733-44. PubMed ID: 12847240
[TBL] [Abstract][Full Text] [Related]
8. Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.
Every AL; Kramer DR; Mannering SI; Lew AM; Harrison LC
J Immunol; 2006 Apr; 176(8):4608-15. PubMed ID: 16585551
[TBL] [Abstract][Full Text] [Related]
9. Early events in peripheral regulatory T cell induction via the nasal mucosa.
Unger WW; Hauet-Broere F; Jansen W; van Berkel LA; Kraal G; Samsom JN
J Immunol; 2003 Nov; 171(9):4592-603. PubMed ID: 14568933
[TBL] [Abstract][Full Text] [Related]
10. B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets.
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
J Immunol; 2004 Sep; 173(6):3631-9. PubMed ID: 15356107
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo.
Yi LA; Hajialiasgar S; Chuang E
Int Immunol; 2004 Apr; 16(4):539-47. PubMed ID: 15039384
[TBL] [Abstract][Full Text] [Related]
12. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
13. A self MHC class II beta-chain peptide prevents diabetes in nonobese diabetic mice.
Chaturvedi P; Agrawal B; Zechel M; Lee-Chan E; Singh B
J Immunol; 2000 Jun; 164(12):6610-20. PubMed ID: 10843721
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes.
Belghith M; Bluestone JA; Barriot S; Mégret J; Bach JF; Chatenoud L
Nat Med; 2003 Sep; 9(9):1202-8. PubMed ID: 12937416
[TBL] [Abstract][Full Text] [Related]
15. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
16. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.
Green EA; Gorelik L; McGregor CM; Tran EH; Flavell RA
Proc Natl Acad Sci U S A; 2003 Sep; 100(19):10878-83. PubMed ID: 12949259
[TBL] [Abstract][Full Text] [Related]
17. A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H; Fukuda-Kawaguchi E; Duramad O; Ishii Y; Tanabe K
J Diabetes Res; 2019; 2019():9430473. PubMed ID: 31781669
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
19. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7.
Szanya V; Ermann J; Taylor C; Holness C; Fathman CG
J Immunol; 2002 Sep; 169(5):2461-5. PubMed ID: 12193715
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]